Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model
- 1 January 2014
- journal article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 24 (1), 142-147
- https://doi.org/10.1016/j.euroneuro.2013.11.007
Abstract
No abstract availableFunding Information
- US Army, Department of Defense Medical Research and Development Program (DM102881)
This publication has 21 references indexed in Scilit:
- Neuropeptide Y and its role in CNS disease and repairExperimental Neurology, 2012
- Pharmacological treatment of anxiety disorders: Current treatments and future directionsJournal of Anxiety Disorders, 2012
- Intranasally Administered Neuropeptide S (NPS) Exerts Anxiolytic Effects Following Internalization Into NPS Receptor-Expressing NeuronsNeuropsychopharmacology, 2012
- Pharmacotherapy for posttraumatic stress disorder: review with clinical applications.Journal of Rehabilitation Research and Development, 2012
- The Neuropeptide Y (NPY)-ergic System is Associated with Behavioral Resilience to Stress Exposure in an Animal Model of Post-Traumatic Stress DisorderNeuropsychopharmacology, 2011
- Post-traumatic stress disorder: emerging concepts of pharmacotherapyEmerging Drugs, 2009
- Relevance of Neuropeptide Y (NPY) in PsychiatryCurrent Topics in Medicinal Chemistry, 2007
- The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress researchJournal of Neuroscience Methods, 2005
- The NPY system in stress, anxiety and depressionNeuropeptides, 2004
- Sniffing neuropeptides: a transnasal approach to the human brainNature Neuroscience, 2002